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Sepsis and meningitis are amongst the leading causes of neonatal deaths in Sub-Saharan Africa 
(SSA). Neonatal sepsis caused around 400000 deaths globally in 2015, half occurring in Africa. 
Despite this, there are few published data on the acute costs of neonatal sepsis or meningitis, 
particularly in low- and middle-income countries, and none in SSA. 
 
Methods 
We collected data on neonates admitted to two hospitals between April 16, 2020 and April 1, 
2021. In South Africa cases were microbiologically confirmed either by culture or PCR. In 
Mozambique clinically suspected and microbiologically confirmed cases were included. Data were 
collected on healthcare resource use and length-of-stay. A caregivers questionnaire gathered 
data on expenditure and caregiving. We used unit costs of healthcare resources in local currencies 
to estimate average healthcare provider cost per patient and average costs per household. Results 
were converted to 2019 international dollars (I$). 
Results 
We enrolled 11 neonates in Mozambique, 18 neonates in South Africa. Mean length-of-stay was 
10 days (median=9; IQR=4-14)) and 16 days (median=15; IQR=13-18). In Mozambique we 
estimated mean household costs of I$49.62 (median=10.19, IQR=5.10-95.12) and hospitalisation 
costs of I$307.58 (median=275.12; IQR=149.43-386.12). In South Africa these costs were I$52.31 
(median=30.82; IQR=19.25-73.08) and I$684.06 (median=653.62; IQR=543.33-827.53), 
respectively. On average, parents in Mozambique spent an extra 52 hours (median=38.5; IQR=19-
86) on caregiving, and in South Africa an extra 76 (median=3.5; IQR=0-120). 
Conclusion 
We found substantial costs associated with acute neonatal bacterial (all-cause) sepsis and 
meningitis in SSA. Our estimates will inform cost-effectiveness analyses of interventions to 
prevent invasive bacterial infections in neonates.   
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LIST OF ABBREVIATIONS 
CI   Confidence Interval 
GBS   Group B Streptococcus 
IQR   Inter Quartile Range  
I$   International Dollar 
LMIC   Low- and Middle-Income Country 
SSA   Sub-Saharan Africa (United Nations region) 
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KEY FINDINGS BOX  
1. WHAT WAS KNOWN AND WHAT IS NEW?  
Globally, the few published studies on acute healthcare costs of neonatal sepsis and/or meningitis 
are from high-income countries, and mainly from the United States. There are no studies from sub-
Saharan Africa despite the high disease burden in this region. Our study provides estimates of health 
care and household costs associated with acute neonatal sepsis and meningitis hospitalisations in 
Mozambique and South Africa.  
  
2. WHAT DID WE DO AND WHAT DID WE FIND?  
Using hospital records and discharge questionnaires of 29 neonates hospitalized in Mozambique and 
South Africa, we estimated mean costs to households and healthcare providers to be I$49.62 
(median=10.19, IQR=5.10-95.12) and I$307.58 (median=275.12; IQR=149.43-386.12), and I$52.31 
(median=30.82; IQR=19.25-73.08) and I$684.06 (median=653.62; IQR=543.33-827.53), respectively 
in 2019 I$.   
  
3. WHAT TO DO NOW IN PROGRAMMES?  
Neonatal complications including infections are an important cost to health systems and families, 
and are an important consideration for inclusion in financial protection schemes. Interventions to 
prevent neonatal sepsis and meningitis could reduce the costs to healthcare providers and 
households, as well as improving health outcomes.  
  
4. WHAT NEXT IN RESEARCH?  
Our results could be used in future research on the cost-effectiveness of interventions to prevent 
neonatal bacterial infections. Further costing studies with larger study populations, across a range of 
hospital settings and countries, and using similar tools to ours would make findings more 
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Although child mortality has halved in the last two decades, deaths in the neonatal period accounted 
for a larger proportion, ~47% (2.4 million) of all under-5 deaths in 2019 [1]. The highest neonatal 
mortality rate is in the Sub-Saharan Africa region (United Nations; SSA), with sepsis and meningitis 
amongst the leading causes of neonatal deaths [2]. Neonatal sepsis, due to pathogens including 
Group B Streptococcus (GBS), led to about 400000 deaths globally in 2015, half of which occurred in 
the African region [3].  
Despite this, there are few published studies on the cost of acute healthcare for sepsis and/or 
meningitis in neonates from low- and middle-income countries (LMICs), with data concentrated 
mainly in the United States [4]. Furthermore, no studies have reported the costs borne by 
households, including indirect costs of care, thereby leading to a potential underestimation of the 
true societal costs [4]. Knowledge of the economic consequences of sepsis and/or meningitis is 
essential for economic evaluations that inform policy-making to prevent invasive bacterial infections 
in neonates [5]. 
The study was conducted both in Mozambique (categorized as a low-income country) and South 
Africa (categorized as an upper-middle income country). In 2019, the gross domestic product per 
capita based on the purchasing power parity was I$1336 in Mozambique and I$13010 in South Africa 
[6]. 
Objective  
This paper is part of a series on GBS worldwide. This paper addresses the lack of empirical data in 
LMICs, and SSA specifically, by estimating the  costs to the healthcare system and households during 
acute episodes of bacterial sepsis and/or meningitis among neonates admitted to hospital  in 
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Data collection  
This costing study was a linked component of a larger study on the outcomes after invasive GBS 
disease in young infants, for which the protocol has been published previously [7]. Data were 
collected among young infants (0–89 days of life) admitted for clinically suspected bacterial sepsis 
and/or meningitis. In South Africa all cases were confirmed microbiologically either by culture or 
detection by polymerase chain reaction (for meningitis cases) in a normally sterile site (blood or 
cerebrospinal fluid). In Mozambique cases were defined based on clinical suspected sepsis and/or 
meningitis at admission, with only some being microbiologically confirmed. Babies born with severe 
congenital abnormalities or culture positive results of organisms considered contaminants or skin 
commensals were excluded [7]. Furthermore, babies born below 32 weeks of gestational age were 
excluded as they may incur additional costs related to being born prematurely.       
We enrolled all participants who met the inclusion criteri  and who were admitted between April 16, 
2020, and April 1, 2021 at the Chris Hani Baragwanath Academic Hospital, a tertiary-academic 
hospital situated in Soweto, South Africa; and the Manhiça District Hospital, the referral hospital for 
the district of Manhiça in Mozambique. The hospitals included in this study are public ones; 
healthcare is normally provided free of charge to all patients in Mozambique and to patients under 6 
years old in South Africa. Data collection took place during the middle of the SARS-CoV-2 pandemic, 
which prevented us from reaching the initial set sample size of 20 neonates per site.  
Most participants were identified prospectively on admission. About 14 % (4/29) of the neonates 
were admitted from birth. These were already in hospital and kept in due to developing sepsis 
and/or meningitis shortly after birth. Neonates who died shortly after admission were not excluded 
from the study. Data on hospital resource use were collected from medical records, including 
information on length-of-stay, drug use, diagnostic tests and surgical procedures (Supplemental 
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the cost per bed day in Mozambique, which was taken from published literature [8]. To capture the 
economic impact of an infant’s hospitalization on households, a questionnaire was administered to 
the main caregiver at the time of discharge or soon after discharge, and included questions on out-
of-pocket payments, medical, transportation and accommodation expenses as well as caregiving 
time (Supplemental Annex Tool 1). Both hospital and household costs only refer to costs incurred 
during the length of neonatal hospital admission. If an infant died in hospital, no questionnaires 
were administered but data were still collected from hospital records. The final version of the 
questionnaire was first piloted before it was administered by trained local research team members. 
A consent form was signed by all neonates’ caregivers participating in the study. 
Analysis  
We estimated household costs associated with the acute episode including direct and indirect costs, 
namely medical, transportation and accommodation costs, as well as costs of informal caregiving. 
Healthcare provider costs were calculated based on the average length-of-stay, use of drugs, 
diagnostics, and supportive care, among others. ost unit costs were provided by the sites in local 
currencies for the year 2019. Wherever estimates were in another currency (i.e. USD) and/or for 
another fiscal year, these were converted into the local currency using the appropriate exchange 
rate and/or inflated using the local consumer price index [9,10]. To facilitate comparison between 
countries, estimates were converted into international dollars (I$) using the purchasing power parity 
conversion factor for 2019 [11]. Given cost data are skewed, we report the median and interquartile 
range (IQR) alongside the mean costs. As a sensitivity analysis, we calculated costs for only 
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Overall, 29 neonates (18 from South Africa and 11 from Mozambique) were enrolled in the study 
population, which is summarized in Table 1 (the sensitivity analysis for Mozambique is summarized 
in Supplementary Table A1.) The mean  gestational age at birth was 38 weeks (median=38; IQR=37-
39). The mean  age on admission was 5 days (median=2; IQR=1-7) in Mozambique and 11 days 
(median=9; IQR=6-13) in South Africa. Among the study participants, 93% (27/29) had sepsis, while 
7% (2/29) were diagnosed with meningitis. Ninety percent (26/29) of neonates were discharged 
alive; two were transferred to another hospital in Maputo, Mozambique (outcome unknown), and 
one South African neonate admitted at 4 days old died after 19 days in hospital following diagnosis 
with sepsis (E. coli). 
Cost estimates 
Hospitalization and household costs for the two countries are described in Table 2. For 
Mozambique, results of the sensitivity analysis including only microbiologically confirmed cases are 
provided in Supplementary Table A2. 
Hospitalization costs 
The mean  length-of-stay of 16 days (median=15; IQR=13-18) in South Africa was substantially longer 
than in Mozambique, which was 10 days (median=9; IQR=4-14) and 11 days (median=10; IQR=7-14) 
when including only microbiologically confirmed cases. The mean hospitalization cost per neonate of 
I$684.06 (median=653.62; IQR=543.33-827.53) in South Africa, was also higher than the cost of 
I$307.58 (median=275.12; IQR=149.43-386.12) in Mozambique. However, for microbiologically 
confirmed cases this increased to I$413.41 (median=386.12; IQR=221.48-514.39), primarily due to 
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Household direct costs 
Most households incurred no direct healthcare expenses related to their child’s acute infection.  The 
mean healthcare expenditure per patient was I$40.04 in Mozambique and I$10.03 in South Africa, 
but median costs were zero in both countries. 
In both countries, food and accommodation at the hospital are provided to caregivers without 
charge, so the main direct costs were transportation expenses. On average, households spent I$9.58 
in Mozambique and I$41.64 in South Africa on transportation. Therefore, the overall direct 
household costs were I$49.62 (median=10.19; IQR=5.10-95.12) and I$52.31(median=30.08; 
IQR=19.25-73.08) in Mozambique and South Africa respectively.  
Household costs of informal care (indirect costs) 
In 97% of cases the caregiver accompanying the child to the hospital was the mother, and otherwise 
the father. Caregivers’ age ranged from 15 to 36 years old. In Mozambique, caregivers reported 
spending 52 hours (median=38.5; IQR=19-86) on extra care. In South Africa, hours of informal care 
varied significantly between caregivers with a mean of 76 hours (median=3.5; IQR=0-120). Amongst 
caregivers, 79% did not earn an income, but all reported that none of the extra time spent caring for 
their child would have been normally spent in paid work.   
DISCUSSION 
The mean healthcare provider costs of treating neonatal sepsis and meningitis were substantially 
higher in South Africa than Mozambique: I$684.06 (median=653.62; IQR=543.33-827.53) versus 
I$307.58 (median=275.12; IQR=149.43-386.12), although this difference was smaller when including 
only microbiologically confirmed cases in Mozambique. Higher costs in South Africa can be partly 
explained by inter-country differences in resource unit costs, and by the shorter length-of-stay and 
more limited standard of care provided in Mozambique. However, the direct costs from the 
household perspective were more similar between the two countries. These were estimated to be 
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73.08) in South Africa. Such expenses werenot considered catastrophic except for two households, 
one in each country, for whom these costs represented over 40% of their monthly income [12]. 
Although, the cost of informal caregiving could not be calculated for most caregivers as they did not 
earn an income, all caregivers reported that the extra hours that they spent with their child would 
not have been spent in paid work. This suggests zero financial opportunity cost for caring for the 
child, but also may reflect the poor communities from which these children come. 
The lack of existing literature on this topic prevents any comparison with other studies in SSA. 
However, based on a few other LMIC studies, the hospitalization costs found in our study appear 
broadly consistent with previously reported cost of treating sepsis (2017 I$642) and meningitis (2017 
I$198-8078) [4]. 
While our study is one of the first to report costs associated with bacterial sepsis and meningitis in 
SSA, it has some limitations. First, our analysis was only descriptive since the small sample size 
prevented us from investigating the determinants of costs and differences between countries. 
Second, we collected data from only one hospital in each country, which together with the sample 
size limits the generalizability of our findings. Third, in Mozambique our results include suspected, as 
well as microbiologically confirmed cases of sepsis, which may underestimate the true costs. Lastly, 
this study does not include the healthcare costs associated with the longer-term impact of the 
disease such as neurodevelopment deficit. Furthermore, this study does not include preterm infants 
because it would require a larger sample size and controlling for potential cofounders, which is 
beyond the s ope of this study. 
Despite these limitations, our multi-country study addresses an important gap in the literature that 
can inform policymaking. We found substantial costs associated with acute neonatal bacterial sepsis 
and meningitis in two countries in SSA, and our estimates will be useful to inform cost-effectiveness 
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Table 1: Descriptive statistics of neonatal inpatients with bacterial sepsis and/or meningitis recruited 
between April 16, 2020 and April 1, 2021. 






Total 11 18 29 
Sex     
    
Male  4 (36%) 12 (67%) 16 (55%) 
Female 7 (64%) 6 (33%) 13 (45%) 
Age in days    
0-6 days 7 (64%) 6 (33%) 13 (45%) 
7-14 days 4 (36%) 8 (44%) 12 (41%) 
15-28 days 0 (0%) 4 (22%) 4(14%) 
Place of delivery     
Home      1 (9%) 0 (0%) 1 (3%) 
Hospital      10 (91%) 18 (100%) 28 (97%) 
Gestational age (weeks)      
32-34 weeks  0 (0%) 2 (11%) 2 (7%) 
35-37 weeks  4 (36%) 6 (33%) 10 (35%) 
>37 weeks  4 (36%) 10 (56%) 14 (48%) 
Unknown 3 (27%) 0 (0%) 3 (10%) 
Admitted at birth     
Yes  4 (36%) 0 (0%) 4 (14%) 
No   7 (64%) 18 (100%) 25 (86%) 
Birthweight (grams)      
<1500 1 (9%) 0 (0%) 1 (3%) 
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2501-3000 1 (9%) 7 (39%) 8 (28%) 
> 3000 5 (45%) 6 (33%) 11 (38%) 
Syndrome        
Meningitis           0 (0%) 2 (11%) 2 (7%) 
Sepsis      11 (100%) 16 (89%) 27 (93%) 
Bacteria detected         
Group B Streptococcus      1 (3%) 8 (44%) 9 (31%) 
Escherichia coli      0 (0%) 6 (33%) 6 (21%) 
Staphylococcus aureus      0 (0%) 4 (22%) 4 (14%) 
Gram negative rod 5 (45%) 0 (0%) 5 (17%) 
Not microbiologically tested 5 (45%) 0 (0%) 5 (17%) 
Length of stay (days)    
0-7 days 5 (45%) 0 (0%) 5 (17%) 
8-14  days 4 (36%) 6 (33%) 10 (34%) 
>15 days 2 (18%) 12 (67%) 14 (48%) 
Discharge status     
Discharged alive      9 (82%) 17 (94%) 26 (90%) 
Referred to another hospital      2 (18%) 0 (0%) 2 (7%) 
Died      0 (0%) 1 (6%) 1 (3%) 
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Table 2: Descriptive analysis of cost data for neonatal sepsis and/or meningitis inpatients (International 
Dollars 2019) 
Hospitalisation costs 
 Mozambique (N=11) South Africa (N=18) 
 Mean Median IQR Mean Median IQR 
Hospital stay (routine ward 
or intensive care bed) 
136.31 
 
123.81 75.66-171.95 379.41 
 
349.62 308.83-419.55 
Supportive care       
Oral feeding 9.26 0.00 0.00-0.00 Included in the hospital daily rate 
NG feeding /   Included in the hospital daily rate 
IV fluid /   Included in the hospital daily rate 
Parenteral feeding /   Included in the hospital daily rate 
Nasal cannula oxygen /   Included in the hospital daily rate 
Phototherapy /   Included in the hospital daily rate 
Hypothermia Data not available  
Antimicrobial therapy       
Antibiotics (first line) 43.68 0.00 0.00-78.77 25.29 14.19 7.02-45.28 
Antibiotics (second line) 3.78 0.00 0.00-0.00 14.04 2.93 0.00-17.26 
Antibiotics (third line) /   0.89 0.00 0.00-0.00 
Antifungals /   0.64 0.00 0.00-0.00 
Anticonvulsants /   2.27 0.00 0.00-0.00 
Other drugs* 0.46 0.46 0.00-0.00 2.45 0.00 0.00-5.02 
Laboratory test       
Blood culture 22.75 0.00 0.00-41.71 19.20 16.08 16.08-24.12 
Lumbar puncture 44.07 0.00 0.00-121.19 27.65 23.70 23-70-23.70 
CSF culture 35.53 0.00 0.00-97.72 17.26 14.79 14.79-14.79 
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Full blood count test 2.72 0.00 0.00-0.00 18.32 18.32 9.16-27.48 
Blood biochemistry /   81.00 36.45 36.45-100.24 
Serum bilirubin test /   5.46 0.00 0.00-5.79 
Blood glucose test 2.96 0.00 0.00-0.00 12.25 4.79 0.00-4.79 
Diagnostic assesment        
Hearing assessment /   Included in the hospital daily rate 
Electrocardiogram /   Included in the hospital daily rate 
Diagnostic imaging       
X-ray /   4.18 0.00 0.00-7.52 
Ultrasound scan /   13.03 0.00 0.00-19.55 
Echocardiogram /   50.13 0.00 0.00-0.00 
TOTAL  307.58 275.12 149.43-386.12 684.35 653.92 543.64-827.83 
Household  expenses  
 Mozambique (N=7)** South Africa (N=18) 
 Mean Median IQR Mean Median IQR 
Healthcare  40.04 0.00 0.00-67.94 10.03 0.00 0.00-0.00 
Transportation  9.58 7.64 4.25-12.74 42.28 30.83 19.25-70.38 
Food and accommodation  0.00 0.00 0.00-0.00 0.00 0.00 0.00-0.00 
TOTAL 49.62 10.19 5.10-95.12 52.31 30.82 19.25-73.08 
* based on one estimate; ** less than 11 due to missing values in the cost of transportation 
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